肿瘤研究与临床
腫瘤研究與臨床
종류연구여림상
CANCER RESEARCH AND CLINIC
2012年
6期
383-385,388
,共4页
罗维贵%黄霞%韦枫%许建国%覃雪梅%苏慧%韦中盛
囉維貴%黃霞%韋楓%許建國%覃雪梅%囌慧%韋中盛
라유귀%황하%위풍%허건국%담설매%소혜%위중성
癌,非小细胞肺%肝细胞核因子3β
癌,非小細胞肺%肝細胞覈因子3β
암,비소세포폐%간세포핵인자3β
Carcinoma,non-small-cell lung%Hepatocyte nuclear factor 3-beta
目的 探讨非小细胞肺癌(NSCLC)组织中肝细胞核因子3β(FoxA 2)的表达情况,及与临床病理因素的关系.方法 分别采用免疫组织化学法和反转录聚合酶链反应,检测80例NSCLC组织及癌旁正常肺组织中FoxA 2蛋白及mRNA的表达,并分析其与患者性别、临床病理类型、吸烟、临床分期、淋巴结转移的关系.结果 FoxA 2蛋白和mRNA在腺癌、鳞状细胞癌、腺鳞癌组织中的表达均低于癌旁正常肺组织(蛋白表达比较,t值分别为187.51、186.43、178.24;mRNA表达比较,t值分别为236.70、260.13、126.27,均P<0.05),不同病理类型间FoxA 2蛋白和mRNA的表达差异无统计学意义(F值分别为1.86、1.69,P> 0.05),在低分化组、Ⅲ期及有淋巴结转移患者的肺组织中的表达显著低于相应的高分化组、Ⅰ~Ⅱ期及无淋巴结转移的患者(蛋白比较t值分别为4.31、3.92、3.41;mRNA比较t值分别为5.44、3.28、5.07,均P<0.05).结论 FoxA 2可能对人类NSCLC的形成起抑制作用,并参与了肿瘤的分化、淋巴结转移过程,且与肺癌的临床分期相关.
目的 探討非小細胞肺癌(NSCLC)組織中肝細胞覈因子3β(FoxA 2)的錶達情況,及與臨床病理因素的關繫.方法 分彆採用免疫組織化學法和反轉錄聚閤酶鏈反應,檢測80例NSCLC組織及癌徬正常肺組織中FoxA 2蛋白及mRNA的錶達,併分析其與患者性彆、臨床病理類型、吸煙、臨床分期、淋巴結轉移的關繫.結果 FoxA 2蛋白和mRNA在腺癌、鱗狀細胞癌、腺鱗癌組織中的錶達均低于癌徬正常肺組織(蛋白錶達比較,t值分彆為187.51、186.43、178.24;mRNA錶達比較,t值分彆為236.70、260.13、126.27,均P<0.05),不同病理類型間FoxA 2蛋白和mRNA的錶達差異無統計學意義(F值分彆為1.86、1.69,P> 0.05),在低分化組、Ⅲ期及有淋巴結轉移患者的肺組織中的錶達顯著低于相應的高分化組、Ⅰ~Ⅱ期及無淋巴結轉移的患者(蛋白比較t值分彆為4.31、3.92、3.41;mRNA比較t值分彆為5.44、3.28、5.07,均P<0.05).結論 FoxA 2可能對人類NSCLC的形成起抑製作用,併參與瞭腫瘤的分化、淋巴結轉移過程,且與肺癌的臨床分期相關.
목적 탐토비소세포폐암(NSCLC)조직중간세포핵인자3β(FoxA 2)적표체정황,급여림상병리인소적관계.방법 분별채용면역조직화학법화반전록취합매련반응,검측80례NSCLC조직급암방정상폐조직중FoxA 2단백급mRNA적표체,병분석기여환자성별、림상병리류형、흡연、림상분기、림파결전이적관계.결과 FoxA 2단백화mRNA재선암、린상세포암、선린암조직중적표체균저우암방정상폐조직(단백표체비교,t치분별위187.51、186.43、178.24;mRNA표체비교,t치분별위236.70、260.13、126.27,균P<0.05),불동병리류형간FoxA 2단백화mRNA적표체차이무통계학의의(F치분별위1.86、1.69,P> 0.05),재저분화조、Ⅲ기급유림파결전이환자적폐조직중적표체현저저우상응적고분화조、Ⅰ~Ⅱ기급무림파결전이적환자(단백비교t치분별위4.31、3.92、3.41;mRNA비교t치분별위5.44、3.28、5.07,균P<0.05).결론 FoxA 2가능대인류NSCLC적형성기억제작용,병삼여료종류적분화、림파결전이과정,차여폐암적림상분기상관.
Objective To investigate the expression and clinical significance of FoxA 2(hepatocyte nuclear factor 3β)in human non-small cell lung cancer(NSCLC)tissues and adjacent normal lung tissue.Methods The expressions of FoxA 2 protein in 80 cases with NSCLC tissues and adjacent normal lung tissue were tested by immunohistochemistry,the expressions of mRNA was detected by RT-PCR.Results The expressions of FoxA 2 both on protein and mRNA in NSCLC lung tissue were significantly less than those of adjacent normal lung tissue(protein expression comparison t value was 187.51,186.43,178.24 respectively;mRNA expression comparison t value was 236.70,260.13,126.27,respectively,P < 0.05).However there was no difference on histopathological variability.F value equal to 1.86 and 1.69,P > 0.05).In low differentiated group,the group of Ⅲ stage,with lymph node metastasis,the expression of FoxA 2 protein and mRNA was less than that in the group of high differentiated,the group of Ⅰ-Ⅱ stage,the group of non lymph node metastasis(pretein expression t values were 4.31,3.92,341,mRNA expression t values were 5.44,3.28,5.07,P<0.05).Conclusion FoxA 2 might inhibit progression of human NSCLC.It may participate in the process of tumor tissue differentiation and lymph node metastasis in NSCLC.